For further details, please refer to the ‘Product Introduction’ section and attached documents.
Amoctin tablets 375 mg, Amoctin Duo syrup
In accordance with the 'Drug Permit Change Order' (Drug Safety Evaluation Division-No. 10, effective date June 2, 2015), the precautions for use of Amoctin Tablet 375 mg and Amoctin Duo Syrup have been changed.
Attachments are original documents and may be in Korean. English editions are labeled separately.
1_Amoxicillin, potassium clavulanate_crabutin tablet 375 mg1_Amoxicillin, potassium clavulanate_crabutin tablet 375 mg.hwp · 50 KBDownload ↓